JJ Swen

2.3k total citations · 2 hit papers
10 papers, 1.4k citations indexed

About

JJ Swen is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Oncology. According to data from OpenAlex, JJ Swen has authored 10 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pediatrics, Perinatology and Child Health, 7 papers in Pharmacology and 4 papers in Oncology. Recurrent topics in JJ Swen's work include Pharmacogenetics and Drug Metabolism (7 papers), Pharmaceutical studies and practices (4 papers) and Cancer therapeutics and mechanisms (2 papers). JJ Swen is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Pharmaceutical studies and practices (4 papers) and Cancer therapeutics and mechanisms (2 papers). JJ Swen collaborates with scholars based in Netherlands, United States and Germany. JJ Swen's co-authors include Teri E. Klein, Henk‐Jan Guchelaar, E D Kharasch, Katrin Sangkuhl, Henry M. Dunnenberger, Kazutaka Shimoda, Julia Stingl, Andrea Gaedigk, Müller Dj and Wolfgang Sadée and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, Pharmacogenomics and CPT Pharmacometrics & Systems Pharmacology.

In The Last Decade

JJ Swen

10 papers receiving 1.4k citations

Hit Papers

Clinical Pharmacogenetics Implementation Consortium (CPIC... 2015 2026 2018 2022 2015 2016 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing
    2015 499 citations Kelly A. Birdwell, Brian S. Decker et al. Clinical Pharmacology & Therapeutics profile →
  2. Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update
    2016 450 citations Katrin Sangkuhl, JJ Swen et al. Clinical Pharmacology & Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
JJ Swen Netherlands 8 917 593 344 243 222 10 1.4k
JS Leeder United States 10 1.3k 1.5× 904 1.5× 317 0.9× 451 1.9× 386 1.7× 10 2.3k
Julia M. Barbarino United States 13 567 0.6× 356 0.6× 160 0.5× 449 1.8× 176 0.8× 14 1.6k
Renzo Wolbold Germany 8 1.2k 1.3× 433 0.7× 248 0.7× 763 3.1× 132 0.6× 9 1.8k
RHN van Schaik Netherlands 8 397 0.4× 317 0.5× 325 0.9× 131 0.5× 71 0.3× 9 856
Vishal Lamba United States 20 1.0k 1.1× 431 0.7× 332 1.0× 831 3.4× 97 0.4× 30 2.2k
Peter Kuehl United States 6 1.3k 1.4× 613 1.0× 420 1.2× 1.0k 4.2× 97 0.4× 8 2.4k
J K Hicks United States 5 722 0.8× 420 0.7× 40 0.1× 156 0.6× 233 1.0× 5 1.2k
Johanna Sistonen Finland 18 728 0.8× 300 0.5× 42 0.1× 345 1.4× 152 0.7× 34 1.3k
Darlene Barr United States 16 644 0.7× 263 0.4× 169 0.5× 547 2.3× 129 0.6× 33 1.6k
Sony Tuteja United States 20 283 0.3× 198 0.3× 223 0.6× 123 0.5× 73 0.3× 71 1.3k

Countries citing papers authored by JJ Swen

Since Specialization
Citations

This map shows the geographic impact of JJ Swen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JJ Swen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JJ Swen more than expected).

Fields of papers citing papers by JJ Swen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JJ Swen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JJ Swen. The network helps show where JJ Swen may publish in the future.

Co-authorship network of co-authors of JJ Swen

This figure shows the co-authorship network connecting the top 25 collaborators of JJ Swen. A scholar is included among the top collaborators of JJ Swen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JJ Swen. JJ Swen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Tops, Bastiaan B.J., et al.. (2022). Genetic variants found in paediatric oncology patients with severe chemotherapy-induced toxicity: A case series. Journal of Oncology Pharmacy Practice. 29(5). 1237–1245. 1 indexed citations
2.
Kanefendt, Friederike, JJ Swen, F. Sörgel, et al.. (2017). Population Modeling Integrating Pharmacokinetics, Pharmacodynamics, Pharmacogenetics, and Clinical Outcome in Patients With Sunitinib‐Treated Cancer. CPT Pharmacometrics & Systems Pharmacology. 6(9). 604–613. 19 indexed citations
3.
Swen, JJ, et al.. (2017). Comparison of the Guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working Group. Clinical Pharmacology & Therapeutics. 103(4). 599–618. 169 indexed citations
4.
Sangkuhl, Katrin, JJ Swen, Müller Dj, et al.. (2016). Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update. Clinical Pharmacology & Therapeutics. 102(1). 37–44. 450 indexed citations breakdown →
5.
Birdwell, Kelly A., Brian S. Decker, Catherine M. Stein, et al.. (2015). Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing. Clinical Pharmacology & Therapeutics. 98(1). 19–24. 499 indexed citations breakdown →
6.
Charehbili, Ayoub, Tahar van der Straaten, JJ Swen, et al.. (2015). Exploratory Analysis of Candidate Germline Gene Polymorphisms in Breast Cancer Patients Treated With Neoadjuvant Anthracycline-Containing Chemotherapy and Associations With Febrile Neutropenia. Pharmacogenomics. 16(11). 1265–1274. 6 indexed citations
7.
Guchelaar, Henk‐Jan, Hans Gelderblom, Tahar van der Straaten, Jan H.M. Schellens, & JJ Swen. (2014). Pharmacogenetics in the Cancer Clinic: From Candidate Gene Studies to Next-Generation Sequencing. Clinical Pharmacology & Therapeutics. 95(4). 383–385. 7 indexed citations
8.
Swen, JJ, Jan den Hartigh, Tahar van der Straaten, et al.. (2014). Effect of CYP3A4*22, CYP3A5*3, and CYP3A Combined Genotypes on Cyclosporine, Everolimus, and Tacrolimus Pharmacokinetics in Renal Transplantation. CPT Pharmacometrics & Systems Pharmacology. 3(2). 1–12. 84 indexed citations
9.
Swen, JJ, et al.. (2013). Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic. 9 indexed citations
10.
Swen, JJ, Ingeborg Wilting, Johannes Mulder, et al.. (2008). Pharmacogenetics: From Bench to Byte. Clinical Pharmacology & Therapeutics. 83(5). 781–787. 194 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by JS Leeder Breakdown of academic impact, for papers by Julia M. Barbarino Breakdown of academic impact, for papers by Renzo Wolbold Breakdown of academic impact, for papers by RHN van Schaik Breakdown of academic impact, for papers by Vishal Lamba Breakdown of academic impact, for papers by Peter Kuehl Breakdown of academic impact, for papers by J K Hicks Breakdown of academic impact, for papers by Johanna Sistonen Breakdown of academic impact, for papers by Darlene Barr Breakdown of academic impact, for papers by Sony Tuteja
Rankless by CCL
2026